Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does HALOPERIDOL Cause Neuroleptic malignant syndrome? 1,244 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 1,244 reports of Neuroleptic malignant syndrome have been filed in association with HALOPERIDOL (Haloperidol). This represents 7.8% of all adverse event reports for HALOPERIDOL.

1,244
Reports of Neuroleptic malignant syndrome with HALOPERIDOL
7.8%
of all HALOPERIDOL reports
118
Deaths
898
Hospitalizations

How Dangerous Is Neuroleptic malignant syndrome From HALOPERIDOL?

Of the 1,244 reports, 118 (9.5%) resulted in death, 898 (72.2%) required hospitalization, and 464 (37.3%) were considered life-threatening.

Is Neuroleptic malignant syndrome Listed in the Official Label?

Yes, Neuroleptic malignant syndrome is listed as a known adverse reaction in the official FDA drug label for HALOPERIDOL.

What Other Side Effects Does HALOPERIDOL Cause?

Drug ineffective (1,771) Off label use (1,136) Toxicity to various agents (872) Extrapyramidal disorder (838) Somnolence (712) Intentional self-injury (636) Drug interaction (596) Weight increased (583) Tremor (579) Condition aggravated (563)

What Other Drugs Cause Neuroleptic malignant syndrome?

QUETIAPINE (1,756) OLANZAPINE (1,748) RISPERIDONE (1,258) ARIPIPRAZOLE (1,138) CLOZAPINE (899) LITHIUM (506) LORAZEPAM (437) PALIPERIDONE (355) VALPROIC ACID (352) SERTRALINE (309)

Which HALOPERIDOL Alternatives Have Lower Neuroleptic malignant syndrome Risk?

HALOPERIDOL vs HALOPERIDOL DECANOATE HALOPERIDOL vs HECTOROL HALOPERIDOL vs HEMIN HALOPERIDOL vs HEPARIN HALOPERIDOL vs HEPARIN\SODIUM

Related Pages

HALOPERIDOL Full Profile All Neuroleptic malignant syndrome Reports All Drugs Causing Neuroleptic malignant syndrome HALOPERIDOL Demographics